These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 22985302)
1. Dual-targeting delivery system for bone cancer: synthesis and preliminary biological evaluation. Jiang B; Cao J; Zhao J; He D; Pan J; Li Y; Guo L Drug Deliv; 2012; 19(7):317-26. PubMed ID: 22985302 [TBL] [Abstract][Full Text] [Related]
2. Selective bone targeting 5-fluorouracil prodrugs: synthesis and preliminary biological evaluation. Ouyang L; He D; Zhang J; He G; Jiang B; Wang Q; Chen Z; Pan J; Li Y; Guo L Bioorg Med Chem; 2011 Jun; 19(12):3750-6. PubMed ID: 21612935 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and preliminary evaluation in vitro of novel naproxen-dendritic peptide conjugates. Ouyang L; Zhang J; Pan J; Yan L; Guo L Drug Deliv; 2009 Aug; 16(6):348-56. PubMed ID: 19606949 [TBL] [Abstract][Full Text] [Related]
4. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer. Wang F; Chen L; Zhang R; Chen Z; Zhu L J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829 [TBL] [Abstract][Full Text] [Related]
5. Multistep targeted nano drug delivery system aiming at leukemic stem cells and minimal residual disease. Shi Y; Su Z; Li S; Chen Y; Chen X; Xiao Y; Sun M; Ping Q; Zong L Mol Pharm; 2013 Jun; 10(6):2479-89. PubMed ID: 23646913 [TBL] [Abstract][Full Text] [Related]
6. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides. Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773 [TBL] [Abstract][Full Text] [Related]
7. Experiments and synthesis of bone-targeting epirubicin with the water-soluble macromolecular drug delivery systems of oxidized-dextran. Yu L; Cai L; Hu H; Zhang Y J Drug Target; 2014 May; 22(4):343-51. PubMed ID: 24405056 [TBL] [Abstract][Full Text] [Related]
8. Albumin-based micro-composite drug carriers with dual chemo-agents for targeted breast cancer treatment. Abedin F; Anwar MR; Asmatulu R; Yang SY J Biomater Appl; 2015 Jul; 30(1):38-49. PubMed ID: 25638169 [TBL] [Abstract][Full Text] [Related]
9. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates. Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660 [TBL] [Abstract][Full Text] [Related]
10. Collagen-hydroxyapatite/cisplatin drug delivery systems for locoregional treatment of bone cancer. Andronescu E; Ficai A; Albu MG; Mitran V; Sonmez M; Ficai D; Ion R; Cimpean A Technol Cancer Res Treat; 2013 Aug; 12(4):275-84. PubMed ID: 23547973 [TBL] [Abstract][Full Text] [Related]
11. Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro. Hengst V; Oussoren C; Kissel T; Storm G Int J Pharm; 2007 Mar; 331(2):224-7. PubMed ID: 17150316 [TBL] [Abstract][Full Text] [Related]
12. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
13. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
14. Development of novel bisphosphonate prodrugs of doxorubicin for targeting bone metastases that are cleaved pH dependently or by cathepsin B: synthesis, cleavage properties, and binding properties to hydroxyapatite as well as bone matrix. Hochdörffer K; Abu Ajaj K; Schäfer-Obodozie C; Kratz F J Med Chem; 2012 Sep; 55(17):7502-15. PubMed ID: 22882004 [TBL] [Abstract][Full Text] [Related]
15. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity. Wang Y; Xin D; Liu K; Zhu M; Xiang J Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889 [TBL] [Abstract][Full Text] [Related]
16. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration. Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297 [TBL] [Abstract][Full Text] [Related]
17. Bone-targeting glycol and NSAIDS ester prodrugs of rhein: synthesis, hydroxyapatite affinity, stability, anti-inflammatory, ulcerogenicity index and pharmacokinetics studies. Cai J; Duan Y; Yu J; Chen J; Chao M; Ji M Eur J Med Chem; 2012 Sep; 55():409-19. PubMed ID: 22901311 [TBL] [Abstract][Full Text] [Related]